Search clinical trials for: Ocrelizumab Placebo
Total 53574 results
-
Chugai PharmaceuticalTerminated
-
National Institute of Allergy and Infectious Diseases...Genentech, Inc.; Rho Federal Systems Division, Inc.; Autoimmunity Centers of...RecruitingMultiple SclerosisUnited States
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, United Kingdom, Hungary, Bulgaria, Puerto Rico, Poland, Argentina, Brazil, Germany, Greece, Italy, Peru, Portugal, Russian Federation, Spain, Turkey, Ukraine, Israel, France, Switzerland, Colombia, Me... and more
-
Hoffmann-La RocheCompleted
-
Johns Hopkins UniversityGlaxoSmithKlineTerminatedMultiple SclerosisUnited States
-
CinnagenCompletedMultiple Sclerosis | Relapsing-RemittingIran, Islamic Republic of
-
Wayne State UniversityRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Fondation Ophtalmologique Adolphe de RothschildRecruiting
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, Hungary, Brazil, Finland, Italy, Germany, Romania, Lithuania, France, Greece, Peru, Portugal, Spain, Switzerland, Bulgaria, Ukraine, Israel, Poland, Austria, New Zealand, Netherlands, Belgium, Mexico, United... and more
-
University of Colorado, DenverGenentech, Inc.Recruiting
-
Genentech, Inc.Completed
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Argentina, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
Yale UniversityGenentech, Inc.TerminatedMultiple Sclerosis | Radiologically Isolated SyndromeUnited States
-
Hoffmann-La RocheCompletedRelapsing Multiple SclerosisUnited States, Belgium, Czechia, Russian Federation, Serbia, Spain, Italy, Netherlands, Finland, Estonia, Brazil, France, Germany, Poland, Switzerland, Ukraine, Peru, Argentina, Lithuania, Slovakia, Portugal, Australia, Hungary, Tunisia, Bulgar... and more
-
Genentech, Inc.Completed
-
Hoffmann-La RocheRecruitingMultiple Sclerosis, Primary ProgressiveCanada, United States, Spain, Croatia, Serbia, Portugal, France, Tunisia, Mexico, Poland, Russian Federation, Australia, Belgium, Italy, United Kingdom, Ukraine, Bulgaria, Colombia, Georgia, Germany, Romania, New Zealand, Lebanon, Aus... and more
-
Hoffmann-La RocheCompletedRelapsing Multiple SclerosisUnited States, Spain, Czechia, Belgium, Italy, Canada, United Kingdom, Germany, Ireland, Turkey, Poland, Russian Federation, Ukraine, Croatia, Argentina, France, Belarus, Brazil, Mexico, Bosnia and Herzegovina, Bulgaria, Slovakia, S... and more
-
Providence Health & ServicesGenentech, Inc.; Institute for Systems BiologyActive, not recruitingMultiple SclerosisUnited States
-
The Methodist Hospital Research InstituteGenentech, Inc.RecruitingSchizophrenia | Schizo-Affective Type of PsychosisUnited States
-
Second Affiliated Hospital of Guangzhou Medical...Not yet recruitingNon-small Cell Lung Cancer
-
University of ChicagoUnknownImmune System Diseases | Multiple SclerosisUnited States
-
Hoffmann-La RochePPD; Laboratory Corporation of America; Illingworth Research GroupActive, not recruitingMultiple Sclerosis | Clinically Isolated SyndromeUnited States, Spain, Switzerland, France, Germany
-
University at BuffaloCompletedMultiple SclerosisUnited States
-
Rennes University HospitalRecruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisFrance
-
Centre Hospitalier Universitaire de NiceRecruitingMultiple SclerosisFrance
-
Dr Recai TurkogluHealth Sciences University Istanbul Haydarpaşa Numune Training and Research...Active, not recruiting
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Spain, Austria, Czechia, Italy, Hungary, Australia, Portugal, Serbia, Canada, Germany, United Kingdom, Poland, Romania, Croatia, Israel, Belgium, Bulgaria, Estonia, Switzerland, Mexico, Lithuania, New Zealand, France, Slo... and more
-
Hoffmann-La RocheActive, not recruitingProgressive Multiple Sclerosis (PMS)United States, Canada, Brazil, France, Netherlands, Ireland, Germany, Italy, Poland, Russian Federation, Spain, Colombia, Morocco, Hungary, Denmark, Lebanon, Mexico, Costa Rica, Bosnia and Herzegovina, Czechia, Egypt, Guatemala, Panama and more
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisBelgium, United Kingdom, Netherlands, Serbia, Poland, Slovakia, Bulgaria, Turkey, Brazil, Italy, Russian Federation, Spain, Austria, Colombia, Romania, Kuwait, Chile, Dominican Republic, Egypt, Montenegro, Panama, Paraguay, Portugal, ... and more
-
Johns Hopkins UniversityGenentech, Inc.Active, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom, Australia, Belgium, Brazil, Croatia, France, Canada, Slovakia, Germany, Netherlands, Norway, Italy, Poland, Switzerland, Romania, Bulgaria, Spain, Mexico, Austria, Portugal, Turkey, Sweden, Argentina, Denmark and more
-
University of California, San FranciscoGenentech, Inc.Completed
-
Genentech, Inc.No longer availableMultiple SclerosisUnited States
-
Brigham and Women's HospitalGenentech, Inc.; Boston Medical CenterNot yet recruiting
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisCanada, United Kingdom, Belgium, Brazil, Croatia, Mexico, Slovakia, Ireland, Netherlands, Estonia, Norway, Denmark, Italy, Poland, Spain, Bulgaria, France, Turkey, Portugal, Sweden, Argentina, Kuwait, Slovenia, Czechia, Hungary, Finland
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Italy, Poland
-
Genentech, Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
Amsterdam UMC, location VUmcRecruitingMultiple Sclerosis, Relapsing-RemittingNetherlands
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AG; Institut du Cerveau et de la Moelle épinièreRecruitingMultiple Sclerosis | Relapse | Primary Progressive Multiple SclerosisFrance
-
Hoffmann-La RochePPD; Laboratory Corporation of America; Illingworth Research GroupActive, not recruitingMultiple Sclerosis | Clinically Isolated SyndromeUnited States, Spain, United Kingdom, Germany
-
Johns Hopkins UniversityGenentech, Inc.Completed
-
NYU Langone HealthGenentech, Inc.CompletedMultiple SclerosisUnited States
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, United Kingdom, Australia, Netherlands, Ireland, Norway, Turkey, Estonia, Denmark, Germany, Italy, Spain, Switzerland, France, Finland, Sweden, Czechia
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
Zhejiang Cancer HospitalRecruitingLocally Advanced Gastric CancerChina
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States